Anti-Allergic Properties of Propolis: Evidence From Preclinical and Clinical Studies
Allergic diseases are a global health burden with increasing prevalence. Side effects of available medications (antihistamines and steroids), lack of patients’ perceived effectiveness and high cost of biologic therapies (omalizumab) are challenges to the clinical management of allergic diseases. As...
Main Authors: | Kong Yen Liew, Nurain Irdayani Kamise, Hui Ming Ong, Poi Yi Aw Yong, Fahmida Islam, Ji Wei Tan, Chau Ling Tham |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.785371/full |
Similar Items
-
Seasonality of allergic diseases: Real‐world evidence from a nationwide population‐based study
by: Young Chan Lee, et al.
Published: (2020-09-01) -
Trends (2007–2019) of major atopic diseases throughout the life span in a large Mexican population
by: Martín Becerril-Ángeles, M.D., et al.
Published: (2023-01-01) -
THE ROLE OF VITAMIN D IN THE IMMUNE RESPONSE AND ALLERGIC DISEASES
by: Meza-Torres Catherine, et al.
Published: (2015-12-01) -
The Role of Diet and Nutrition in Allergic Diseases
by: Ping Zhang
Published: (2023-08-01) -
Allergic multimorbidity is associated with self‐reported anaphylaxis in adults—A cross‐sectional questionnaire study
by: Tuuli Thomander, et al.
Published: (2022-07-01)